By Michael Lohmuller, Nicole Cook, and Logan Pauley

The illicit synthetic drug networks that fuel the ongoing opioid epidemic in the United States continue to evolve and adapt to changing incentives and pressures, finding innovative ways to exploit technology and increased global interconnectivity. C4ADS investigated these drug supply chains, conducting extensive multilingual analysis of Chinese corporate entities, the clear web, and social media, in order to better understand the methods by which they operate.   

Washington, DC: C4ADS 2020, 45p.